SJM
12
-2
UAL
80
3
DRI
48
-5
MAS
54
-4
COP
45
-2
MAC
62
2
IR
65
2
SYF
83
2
ISRG
66
-3
VNO
49
3
HPQ
46
2
T
30
-2
HUM
31
-4
ETR
52
-2
DOV
69
-2
CVS
37
5
BSX
52
-2
BEN
48
2
OXY
41
9
MLM
60
-6
SJM
12
-2
UAL
80
3
DRI
48
-5
MAS
54
-4
COP
45
-2
MAC
62
2
IR
65
2
SYF
83
2
ISRG
66
-3
VNO
49
3
HPQ
46
2
T
30
-2
HUM
31
-4
ETR
52
-2
DOV
69
-2
CVS
37
5
BSX
52
-2
BEN
48
2
OXY
41
9
MLM
60
-6
Financhill
Back

ProShares S&P Kensho Cleantech ETF Vs. Kymera Therapeutics, Inc. Sector Stock Comparison

Buy
59

CTEX
ProShares S&P Kensho Cleantech ETF

Last Price:
$38.00
Seasonality Move:
-6.55%
Buy
87

KYMR
Kymera Therapeutics, Inc.

Last Price:
$89.98
Seasonality Move:
7.7%
Buy
59
ProShares S&P Kensho Cleantech ETF (CTEX) is a Buy

Is ProShares S&P Kensho Cleantech ETF a Buy, Sell or Hold?

  • The current ProShares S&P Kensho Cleantech ETF [CTEX] share price is $37.34. The Score for CTEX is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • CTEX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
87
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $86.88. The Score for KYMR is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

CTEX Stock Price Chart

What is ProShares S&P Kensho Cleantech ETF's stock price today?

  • The ProShares S&P Kensho Cleantech ETF share price today is $37.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CTEX is experiencing slight buying pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $86.88
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

CTEX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.36 Buy
Relative Strength Index (14 RSI): 58.31 Buy
Chaikin Money Flow: 1295 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.63 - 38.01) Buy
Bollinger Bands (100): (25.8 - 35.98) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.97 Buy
Relative Strength Index (14 RSI): 72.81 Buy
Chaikin Money Flow: -897315 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.72 - 73.96) Buy
Bollinger Bands (100): (43.27 - 64.19) Buy

CTEX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.12 Buy
20-day SMA: 35.16 Buy
50-day SMA: 35.5 Buy
200-day SMA: 25.13 Buy
8-day EMA: 36.19 Buy
20-day EMA: 35.66 Buy
50-day EMA: 33.91 Buy
200-day EMA: 19.69 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.38 Buy
20-day SMA: 67.89 Buy
50-day SMA: 62.54 Buy
200-day SMA: 44.51 Buy
8-day EMA: 75.59 Buy
20-day EMA: 69.41 Buy
50-day EMA: 62.91 Buy
200-day EMA: 49.79 Buy

ProShares S&P Kensho Cleantech ETF Earnings Growth & CTEX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.36 per share.

ProShares S&P Kensho Cleantech ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):